Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Maman Ibrahim - Why Pharma Boards Confuse Scenario Models With Risk Measurements
Why Pharma Boards Confuse Scenario Models With Risk Measurements
Forbes

Maman Ibrahim is a cyber and digital risk executive, helping boards, CRO, CIO, and CISO turn risk work into decisions, delivery, and proof. A large number can change the weather in a boardroom. The chair looks up. The CFO stops scrolling. Someone…

newstatesman.com - Nick Dearden - The US pharma deal is a crime against UK healthcare
The US pharma deal is a crime against UK healthcare
The Newstatesman

This week, we took the first step in a legal challenge which we hope will force a change of heart in government towards its pharma “deal” with the United States. Signed with Donald Trump in December, Keir Starmer heralded the…

chinadaily.com.cn - Pharma firms obliged to make medicines even if unprofitable - Opinion
Pharma firms obliged to make medicines even if unprofitable - Opinion
中国日报网

Man buys medicine with the help of a pharmacy sales person in Chongqing municipality, Southwest China, July 21, 2014. [Photo/IC] AFTER MEDIA REPORTS about a shortage, even in some big hospitals, of mercapatopurinem, a medication used to treat…

newswire.ca - Corporation JAMP Pharma - Orimed Pharma Expands PrLuxa-D™ Portfolio to Enhance Vitamin D Treatment Options in Canada
Orimed Pharma Expands PrLuxa-D™ Portfolio to Enhance Vitamin D Treatment Options in Canada
CNW

Orimed Pharma, an affiliate of the JAMP Pharma Group, is expanding the Luxa-D portfolio with new strengths of vitamin D: 5 000, 10 000, 25 000 and 50 000 International Units (IU) These new formulations offer additional dosage options in the…

benzinga.com - Mohd Haider - Liminatus Pharma Is Trending Overnight - Here's Why LIMN Stock Surged Over 79% In After-Hours Session - L
Liminatus Pharma Is Trending Overnight - Here's Why LIMN Stock Surged Over 79% In After-Hours Session - L
Benzinga

Liminatus Pharma Inc. (NASDAQ:) shares are trending on Friday. LIMN shares surged 79.34% to $0.34 after the bell on Thursday. The stock of the biopharmaceutical company had experienced an intraday drop of 1.16%, closing at $0.19, according to…

prospect.org - Susanna Beiser - Can You Support Medicare for All and Take Money From Big Pharma?
Can You Support Medicare for All and Take Money From Big Pharma?
The American Prospect

The 2026 midterm season has so far been marked by the cost-of-living crisis and a desire to bring in a new guard of spunkier, younger politicians who will fight President Trump. In Colorado's First Congressional District, which includes Denver and…

marketbeat.com - 49,855 Shares in Royalty Pharma PLC $RPRX Acquired by Partners Group Holding AG
49,855 Shares in Royalty Pharma PLC $RPRX Acquired by Partners Group Holding AG
MarketBeat

Partners Group Holding AG bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 49,855 shares of the…

marketbeat.com - Marathon Asset Management Ltd Has $15 Million Stake in Royalty Pharma PLC $RPRX
Marathon Asset Management Ltd Has $15 Million Stake in Royalty Pharma PLC $RPRX
MarketBeat

Marathon Asset Management Ltd reduced its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 8.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned…

rediff.com - Nandita Malik - Indian Stock Market Rally: Sensex, Nifty Up Amid Global Optimism, Lower Oil Prices
Indian Stock Market Rally: Sensex, Nifty Up Amid Global Optimism, Lower Oil Prices
Rediff.com

Indian benchmark equity indices, Sensex and Nifty, surged in early trade, buoyed by a positive global market rally and a significant drop in crude oil prices, as investors anticipate a swift resolution to the West Asia conflict. Indian benchmark…

thehindu.com - Pti - Stock markets rally in early trade tracking positive trend in global peers, easing oil prices
Stock markets rally in early trade tracking positive trend in global peers, easing oil prices
The Hindu

Benchmark equity indices were trading higher in early trade on Thursday (May 21, 2026), helped by easing oil prices and a sharp rally in global markets amid hopes that the West Asia conflict would end soon. The 30-share BSE Sensex climbed 327.74…

zerohedge.com - Tyler Durden - UK COVID Inquiry's Endorsement Of Censorship Sets Chilling Precedent
UK COVID Inquiry's Endorsement Of Censorship Sets Chilling Precedent
Zero Hedge

According to the UK's Covid Inquiry, whose fourth report was published in April, there was “in principle, nothing unlawful or inappropriate in the government monitoring publicly available social media to identify potential trends in…

townhall.com - Jared Whitley - Cassidy's Loss Is a Win for Rural Americans Who Depend on Successful 340B Drug-Discount Program
Cassidy's Loss Is a Win for Rural Americans Who Depend on Successful 340B Drug-Discount Program
Townhall

Recent Republican primaries have given us a lot to celebrate, as so many establishment candidates have lost to America First ones. One that's caught a lot of attention is the loss of Senator Bill Cassidy of Louisiana, who was such a RINO he could…

thehindu.com - The Hindu Bureau - Kurnool police book YSRCP youth leader for allegedly defaming Industries Minister
Kurnool police book YSRCP youth leader for allegedly defaming Industries Minister
The Hindu

The Kurnool police on Tuesday registered a case against YSR Congress Party (YSRCP) youth leader Byreddy Siddharth Reddy for allegedly insulting and harming the reputation of Industries and Commerce Minister T.G. Bharath Gupta. Mr. Siddharth Reddy…

seekingalpha.com - Gary Alexander - GoodRx: Evident Stabilization, But GLP-1 Dependence Is A Risk (Upgrade) (NASDAQ:GDRX)
GoodRx: Evident Stabilization, But GLP-1 Dependence Is A Risk (Upgrade) (NASDAQ:GDRX)
Seeking Alpha

Gary Alexander 33.88K Followers I'm upgrading GoodRx to a 'Neutral' rating following its recent Q1 earnings print, which showed a return to subscriber growth. Interest in weight loss medication has provided a boost to specialty-specific…

forbes.com - Amy Feldman - Inside Incyte's $120 Million AI For Drug Development Deal
Inside Incyte's $120 Million AI For Drug Development Deal
Forbes

In this week's edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure's $7 billion valuation, and more. To get it in your inbox, subscribe here. Genesis Molecular AI's Evan Feinberg (left) and Incyte's…

Receive a Daily briefing on Pharma Industry News

Get Started